This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength?
by Zacks Equity Research
Eton Pharmaceuticals (ETON) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ETONNegative Net Change LEGNNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Guidewire Software (GWRE) Surges 11.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
Guidewire Software (GWRE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
GWRENegative Net Change PLUSNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
FTAI Aviation (FTAI) Moves 9.8% Higher: Will This Strength Last?
by Zacks Equity Research
FTAI Aviation (FTAI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
FTAINegative Net Change KTOSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Recursion Pharmaceuticals (RXRX) Moves 8.9% Higher: Will This Strength Last?
by Zacks Equity Research
Recursion Pharmaceuticals (RXRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
RXRXNegative Net Change ENTANegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Verve Therapeutics (VERV) Moves 18.7% Higher: Will This Strength Last?
by Zacks Equity Research
Verve Therapeutics (VERV) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
KPTINegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
CRISPR Therapeutics (CRSP) Moves 6.5% Higher: Will This Strength Last?
by Zacks Equity Research
CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CRSPPositive Net Change TARSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in RadNet (RDNT): Can Its 5.9% Jump Turn into More Strength?
by Zacks Equity Research
RadNet (RDNT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
RDNTNegative Net Change ASTHNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Solaris Energy Infrastructure, Inc. (SEI) Soars 9.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Solaris Energy Infrastructure, Inc. (SEI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
SEINegative Net Change NOVPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Celestica (CLS) Soars 4.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Celestica (CLS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CLSPositive Net Change SANMPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Schrodinger (SDGR) Moves 14.1% Higher: Will This Strength Last?
by Zacks Equity Research
Schrodinger (SDGR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
SDGRNegative Net Change FLGTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
ExlService Holdings (EXLS) Surges 5.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
ExlService Holdings (EXLS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
EXLSNegative Net Change CNDTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Sangoma Technologies Corporation (SANG) Soars 5.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Sangoma Technologies Corporation (SANG) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
SANGNegative Net Change UDMYNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Rigetti Computing (RGTI) Soars 42.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Rigetti Computing (RGTI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
RGTINegative Net Change ASANNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Limbach (LMB) Surges 6.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
Limbach (LMB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
LMBNegative Net Change ROLNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Urban Outfitters (URBN) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
URBNPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
Liquidia Technologies (LQDA) Moves 5.7% Higher: Will This Strength Last?
by Zacks Equity Research
Liquidia Technologies (LQDA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
LQDANegative Net Change PBYINegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Keros Therapeutics (KROS) Soars 5.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Keros Therapeutics (KROS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
KROSNegative Net Change RVMDNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Rhythm Pharmaceuticals (RYTM) Soars 5.5%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Rhythm Pharmaceuticals (RYTM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
RYTMNegative Net Change RARENegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Oracle (ORCL) Moves 7.2% Higher: Will This Strength Last?
by Zacks Equity Research
Oracle (ORCL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ORCLPositive Net Change CDNSNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Dollar General (DG) Stock Jumps 5.1%: Will It Continue to Soar?
by Zacks Equity Research
Dollar General (DG) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
DGNegative Net Change TJXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Cracker Barrel (CBRL) Surges 13.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
Cracker Barrel (CBRL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CBRLPositive Net Change CAKENegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Banco Macro (BMA) Moves 4.6% Higher: Will This Strength Last?
by Zacks Equity Research
Banco Macro (BMA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
BMANegative Net Change BMONegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Evolus (EOLS) Surges 28.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Evolus (EOLS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
EOLSNegative Net Change OGIPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Viant (DSP) Soars 7.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Viant (DSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
DSPNegative Net Change IENegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Brainsway (BWAY) Moves 8.0% Higher: Will This Strength Last?
by Zacks Equity Research
Brainsway (BWAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
BWAYPositive Net Change ATRCPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today